GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Cyclically Adjusted Book per Share

Theratechnologies (Theratechnologies) Cyclically Adjusted Book per Share : $0.85 (As of Feb. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Theratechnologies's adjusted book value per share for the three months ended in Feb. 2024 was $-0.535. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.85 for the trailing ten years ended in Feb. 2024.

During the past 12 months, Theratechnologies's average Cyclically Adjusted Book Growth Rate was -18.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -11.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -9.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -11.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Theratechnologies was 2.10% per year. The lowest was -20.10% per year. And the median was -11.60% per year.

As of today (2024-06-09), Theratechnologies's current stock price is $1.22. Theratechnologies's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2024 was $0.85. Theratechnologies's Cyclically Adjusted PB Ratio of today is 1.44.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Theratechnologies was 25.79. The lowest was 0.17. And the median was 6.05.


Theratechnologies Cyclically Adjusted Book per Share Historical Data

The historical data trend for Theratechnologies's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Cyclically Adjusted Book per Share Chart

Theratechnologies Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.54 1.36 1.33 1.12 0.90

Theratechnologies Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.07 1.08 0.99 0.90 0.85

Competitive Comparison of Theratechnologies's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Theratechnologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theratechnologies's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theratechnologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Theratechnologies's Cyclically Adjusted PB Ratio falls into.



Theratechnologies Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Theratechnologies's adjusted Book Value per Share data for the three months ended in Feb. 2024 was:

Adj_Book= Book Value per Share /CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=-0.535/125.4675*125.4675
=-0.535

Current CPI (Feb. 2024) = 125.4675.

Theratechnologies Quarterly Data

Book Value per Share CPI Adj_Book
201405 0.961 99.394 1.213
201408 0.693 99.315 0.875
201411 0.450 99.078 0.570
201502 0.398 99.078 0.504
201505 0.443 100.263 0.554
201508 0.884 100.579 1.103
201511 0.913 100.421 1.141
201602 0.908 100.421 1.134
201605 1.146 101.765 1.413
201608 1.196 101.686 1.476
201611 1.213 101.607 1.498
201702 1.692 102.476 2.072
201705 1.811 103.108 2.204
201708 1.931 103.108 2.350
201711 1.785 103.740 2.159
201802 1.688 104.688 2.023
201805 1.586 105.399 1.888
201808 1.863 106.031 2.205
201811 1.822 105.478 2.167
201902 1.775 106.268 2.096
201905 1.630 107.927 1.895
201908 1.561 108.085 1.812
201911 1.291 107.769 1.503
202002 1.074 108.559 1.241
202005 0.801 107.532 0.935
202008 0.443 108.243 0.513
202011 0.167 108.796 0.193
202102 1.722 109.745 1.969
202105 1.481 111.404 1.668
202108 1.130 112.668 1.258
202111 0.747 113.932 0.823
202202 0.427 115.986 0.462
202205 -0.490 120.016 -0.512
202208 -0.759 120.569 -0.790
202211 -0.933 121.675 -0.962
202302 -1.335 122.070 -1.372
202305 -1.716 124.045 -1.736
202308 -1.723 125.389 -1.724
202311 -0.454 125.468 -0.454
202402 -0.535 125.468 -0.535

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Theratechnologies  (NAS:THTX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Theratechnologies's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.22/0.85
=1.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Theratechnologies was 25.79. The lowest was 0.17. And the median was 6.05.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Theratechnologies Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Theratechnologies (Theratechnologies) Business Description

Industry
Traded in Other Exchanges
Address
2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.

Theratechnologies (Theratechnologies) Headlines

From GuruFocus